期刊文献+

浅表性膀胱癌组织学形态及Ki-67、p53表达与肿瘤复发的关系 被引量:2

The correlation between recurrence of superficial bladder cancer and histology manifestation or Ki-67, p53 expression
下载PDF
导出
摘要 目的探讨浅表性膀胱癌组织学形态以及Ki67、p53表达与肿瘤复发的关系。方法将54例浅表性膀胱癌分为复发组和无复发组。复习肿瘤组织学形态并根据1998年WHO/ISUP分类标准进行重新分类。免疫组化法检测Ki67和p53的表达并比较复发组与无复发组的差异。结果在平均32个月的随访中,28例复发,占52%,其中5例为低度恶性潜能的乳头状移行细胞瘤,14例为低级别乳头状瘤,9例为高级别乳头状瘤。而26例无复发肿瘤中4例为乳头状瘤,12例为低度恶性潜能的乳头状移行细胞瘤,8例为低别乳头状瘤,2例为高级别乳头状瘤。低度恶性潜能肿瘤复发率为29.4%(5/17),低级别和高级别乳头状瘤术后复发率分别为63.6%(14/22)和81.8%(9/11),而乳头状瘤无一例复发。Ki67和p53阳性率在两组之间有明显差别,复发组均明显高于无复发组(P<0.05)。在乳头状瘤病例中,Ki67和p53联合表达的病例复发率明显高于无联合表达者(P<0.01)。结论浅表性膀胱癌术后复发与组织学有关,Ki67、p53阳性表达尤其是联合阳性表达对判断膀胱癌复发具有重要意义。 Objective To approach the correlation between histology manifestation or Ki-67, p53 expression and superficial bladder cancer. Methods 54 cases of superficial bladder cancer were classified into two groups(with and without recurrence). The histological morphology was reviewed according to the 1998 WHO/ISUP classification. The expression of both Ki-67 and p53 was detected with immunohistochemical method, and a comparison was made between withand without recurrence group. Results The average duration of follow-up survey for the patients was 32 months. Among the 54 patients, 28 got recurrence. Of the recurred cases, 5 were papillary urothelial neoplasm of low malignant potential (PUNLMP), 14 were low grade papillary urothelial carcinoma (LGPUC), and 9 were high grade urothelial papillary carcinoma (HGPUC). While among the 26 cases without recurrence, 4 were papilloma, 12 were PUTLMP, 8 were LGPUC, and 2 were HGPUC. The recurrence rate was 29. 4% (5/17) in PUTLMP, 63. 6% (14/22) and 81.8% (9/11) in LGPUC and HGPUC, respectively. There was a significant difference in Ki-67 and p53 expression between the recurrence and non-recurrence groups, the positive rate in recurrence group was significantly higher than that in non-recurrence group (P〈0.05). Among the cases of papillary carcinoma, the recurrence rate in the cases with combined Ki-67 and p53 expression was significantly higher than that in the cases with only Ki-67 or p53 expression alone. Conclusion The recurrence of superficial bladder cancer is closely correlated with its histological manifestation. The expression of Ki-67 and p53, especially the positive combined expression played an important role in the judgment of recurrence.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2005年第9期804-806,共3页 Medical Journal of Chinese People's Liberation Army
关键词 膀胱肿瘤 KI-67抗原 基因 p53 bladder neoplasms Ki-67 antigen genes, p53
  • 相关文献

参考文献9

  • 1Migaldi M, Rossi G, Maiorana A et al. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. BJU Int, 2004,94(3):311.
  • 2Lopez-Beltran A, Luque RJ, Alvarez-KJ et al. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol, 2004 ,122(3):444.
  • 3Magi-Galluzzi C, Epstein JI et al. Urothelial papilloma of the bladder: a review of 34 de novo cases. Am J Surg Pathol, 2004,28(12):1615.
  • 4Fujii Y, Kawakami S, Koga F et al. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int, 2003,92(6):559.
  • 5Montironi R, Lopez A. The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary. Int J Surg Pathol, 2005,13(2):143.
  • 6Saint F, Le Frere Belda MA, Quintela R et al. Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Guerin (BCG). Eur Urol, 2004,45(4):475.
  • 7Peyromaure M, Weibing S, Sebe P et al. Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy. Urology, 2002,59(3):409.
  • 8Popov Z, Gil-Diez-De-Medina S et al. Ravery V. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. Urol Oncol, 2004,22(2):93.
  • 9Stavropoulos NE, Filiadis I, Ioachim E et al. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer. Anticancer Res, 2002, 22(6B):3759.

同被引文献14

  • 1王平,董德平,陈莉,张剑平,曹斌.Survivin、Ki67在膀胱癌中的表达及其临床意义[J].中华实验外科杂志,2006,23(6):765-765. 被引量:15
  • 2Al-SUKHUN S, HUSSAIN M. Current understanding of the biology of advanced bladder cancer [J]. Cancer,2003,97(Suppl 8) :2064-2075.
  • 3WANG X, JONES T D, MACLENNAN G T, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications [ J ]. Anticancer Res, 2005, 25(3B) :2001-2004.
  • 4PISTON E, FAYNEL J. p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumors with a higher risk of progression [ J]. Br J Cancer,2005,93 (2) :242-247.
  • 5BOZLU M, ORHAN D, BALTACL S, et al. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nuclear organizer region in transitional cell carcinoma of the bladder [J]. Int Urol Nephrol,2002,33(1):59.
  • 6PFISTER C, LAEOMBE K, VEZINA M C, et al. Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors[J]. Hum Pathol,1999,30 (11) :1350.
  • 7Wu TT,Lee YH,Huang JK.p53 mutation and bel-2 expression in transitional cell carcinoma of the urinary bladder[J].Zhonghua Yi Xue Za Zhi (Taipei),2001 ;64(1):9-14.
  • 8Wang X,Jones TD,Maclennan GT,et al.p53 expression in small cell carcinoma of the urinary bladder:biological and prognostic implications[J].Anticancer Res,2005;25(3B):2001-4.
  • 9Piston E,Faynel J.p53 immunodetoction of liquid-based processed urinary samples helps to identify bladder tumors with a higher risk of progression[J].Br J Cancer,2005 ;93 (2):242-7.
  • 10Bozlu M,Orhan D,Bahael S,et al.The prognostic value of proliferating cell nuclear antigen,Ki-67 and nuclear organizer region in transitional cell carcinoma of the bladder[J].Int Urol Nephrol,2002 ;33(1):59.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部